41
/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
May 31, 2026
3512562
319423
2
Create a timeline
Public Timelines
For companies For educational institutions For teachers For students Dashboard
For educational institutions For teachers For students Dashboard
FAQ
Create a timeline
Public timelines
FAQ
About & FeedbackTermsPrivacyFAQ
Support 24/7  
DashboardGet premium
Donate

jan 1, 2013 - Ado-Trastuzumab Emtansine (T-DM1)

Description:

For the treatment of patients with HER2-positive breast cancer previously treated with trastuzumab and/or a taxane drug, the FDA recommends ado-trastuzumab emtansine (T-DM1).

Added to timeline:

Cancer

ByTrinity Ozias
14 Nov 2019
0
0
309

Date:

jan 1, 2013
Now
~ 13 years ago
About & FeedbackTermsPrivacyFAQ
Support 24/7  
DashboardGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL